These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 21751956

  • 1. Factors influencing the allergenicity and adjuvanticity of allergens.
    Deifl S, Bohle B.
    Immunotherapy; 2011 Jul; 3(7):881-93. PubMed ID: 21751956
    [Abstract] [Full Text] [Related]

  • 2. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S, Deifl S, Bohle B.
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE, Monasterolo G.
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [Abstract] [Full Text] [Related]

  • 4. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
    Wilcock LK, Francis JN, Durham SR.
    Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
    [Abstract] [Full Text] [Related]

  • 5. Allergen-related approaches to immunotherapy.
    Rolland JM, Gardner LM, O'Hehir RE.
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [Abstract] [Full Text] [Related]

  • 6. Allergen-specific immunotherapy: an update on immunological mechanisms of action.
    Ciprandi G, Marseglia GL, Tosca MA.
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):34-7. PubMed ID: 16700191
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C, Ipsen H, Mayer L, Slotosch C, Petersen A, Würtzen PA, Hertl M, Pfützner W.
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [Abstract] [Full Text] [Related]

  • 9. Allergen-specific T lymphocytes as targets for specific immunotherapy: striking at the roots of type I allergy.
    Bohle B.
    Arch Immunol Ther Exp (Warsz); 2002 Nov; 50(4):233-41. PubMed ID: 12371619
    [Abstract] [Full Text] [Related]

  • 10. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T, Linhart B, Sonneck K, Blatt K, Herrmann H, Valent P, Stoecklinger A, Lupinek C, Thalhamer J, Fedorov AA, Almo SC, Valenta R.
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [Abstract] [Full Text] [Related]

  • 11. [New approaches for allergen-specific immunotherapy].
    Cantillo JF, Puerta L.
    Biomedica; 2010 Apr; 30(3):440-53. PubMed ID: 21713346
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M, Swoboda I, Marth K, Valenta R.
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [Abstract] [Full Text] [Related]

  • 14. [New concepts in therapy of type I allergic diseases].
    Valenta R, Steinberger P, Vrtala S, Grote M, Laffer S, Sperr WR, Valent P, Kraft D, Scheiner O.
    Wien Klin Wochenschr; 1993 Mar; 105(23):682-6. PubMed ID: 7508663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunotherapy with monomethoxypolyethylene glycol modified allergens.
    Dreborg S, Akerblom EB.
    Crit Rev Ther Drug Carrier Syst; 1990 Mar; 6(4):315-65. PubMed ID: 2186872
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeting dendritic cells in allergen immunotherapy.
    Novak N.
    Immunol Allergy Clin North Am; 2006 May; 26(2):307-19, viii. PubMed ID: 16701146
    [Abstract] [Full Text] [Related]

  • 19. Immunological mechanisms of allergen-specific immunotherapy.
    Larché M, Akdis CA, Valenta R.
    Nat Rev Immunol; 2006 Oct; 6(10):761-71. PubMed ID: 16998509
    [Abstract] [Full Text] [Related]

  • 20. [Polymorphism in allergens].
    Lagares A, Puerta L, Caraballo L.
    Biomedica; 2002 Mar; 22(1):51-62. PubMed ID: 11957365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.